Log in to save to my catalogue

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_92921d97535b4d4ea6eb9d82c6c12859

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro

About this item

Full title

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro

Publisher

Basel: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2021-11, Vol.14 (11), p.1136

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

There is no definite cure for Alzheimer’s disease (AD) due to its multifactorial origin. Drugs that inhibit acetylcholinesterase (AChE), such as rivastigmine, are promising symptomatic treatments for AD. Emerging evidence suggests that insulin therapy can hinder several aspects of AD pathology. Insulin has been shown to modify the activity of AChE,...

Alternative Titles

Full title

The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_92921d97535b4d4ea6eb9d82c6c12859

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_92921d97535b4d4ea6eb9d82c6c12859

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph14111136

How to access this item